Related Experiment Video
Updated: Dec 20, 2025

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.0K
Myelodysplastic/myeloproliferative neoplasms - Justified inclusion as unique biological entities
1Divison of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Best Practice & Research. Clinical Haematology
|May 29, 2020
Abstract
No abstract available in PubMed .

